Melanoma Genome Sequence Shows PREX2 as a Significantly Mutated Gene
Berger, Hodis et al., Nature
A team led by investigators at the Broad Institute reports having sequenced the genomes of 25 metastatic melanomas and matched germline DNA, through which it identified a "wide range of point mutation rates," and PREX2 as a significantly mutated gene in melanomas.
Pathway Genomics Joins the American Clinical Laboratory Association
February 14, 2012
Pathway Genomics is now a member of the American Clinical Laboratory Association, according to a company news release. Pathway Genomics specializes in genetic tests, especially for drug response, pregnancy planning, and disease risk assessment for conditions like Alzeimer's disease, Type 2 diabetes, and lupus, among others. "Pathway Genomics is another example of our nation's laboratories that are at the forefront of genetic testing and personalized medicine," says Alan Mertz, the ACLA president, in a statement.